Risk of Human Papillomavirus-Associated Cancers Among Persons With AIDS

被引:351
作者
Chaturvedi, Anil K. [1 ]
Madeleine, Margaret M. [2 ]
Biggar, Robert J. [3 ]
Engels, Eric A. [1 ]
机构
[1] NCI, Infect & Immunoepidemiol Branch, Div Canc Epidemiol & Genet, NIH, Rockville, MD 20852 USA
[2] Fred Hutchinson Canc Res Ctr, Program Epidemiol, Seattle, WA 98104 USA
[3] State Serum Inst, Copenhagen, Denmark
来源
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE | 2009年 / 101卷 / 16期
基金
美国国家卫生研究院;
关键词
ACTIVE ANTIRETROVIRAL THERAPY; HUMAN-IMMUNODEFICIENCY-VIRUS; SQUAMOUS INTRAEPITHELIAL LESIONS; HIV-INFECTED PERSONS; ANAL CANCER; NATURAL-HISTORY; POSITIVE WOMEN; UNITED-STATES; CELL COUNT; ADULTS;
D O I
10.1093/jnci/djp205
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background Although risk of human papillomavirus (HPV)-associated cancers of the anus, cervix, oropharynx, penis, vagina, and vulva is increased among persons with AIDS, the etiologic role of immunosuppression is unclear and incidence trends for these cancers over time, particularly after the introduction of highly active antiretroviral therapy in 1996, are not well described. Methods Data on 499 230 individuals diagnosed with AIDS from January 1, 1980, through December 31, 2004, were linked with cancer registries in 15 US regions. Risk of in situ and invasive HPV-associated cancers, compared with that in the general population, was measured by use of standardized incidence ratios (SIRs) and 95% confidence intervals (CIs). We evaluated the relationship of immunosuppression with incidence during the period of 4-60 months after AIDS onset by use of CD4 T-cell counts measured at AIDS onset. Incidence during the 4-60 months after AIDS onset was compared across three periods (1980-1989, 1990-1995, and 1996-2004). All statistical tests were two-sided. Results Among persons with AIDS, we observed statistically significantly elevated risk of all HPV-associated in situ ( SIRs ranged from 8.9, 95% CI = 8.0 to 9.9, for cervical cancer to 68.6, 95% CI = 59.7 to 78.4, for anal cancer among men) and invasive ( SIRs ranged from 1.6, 95% CI = 1.2 to 2.1, for oropharyngeal cancer to 34.6, 95% CI = 30.8 to 38.8, for anal cancer among men) cancers. During 1996-2004, low CD4 T-cell count was associated with statistically significantly increased risk of invasive anal cancer among men (relative risk [RR] per decline of 100 CD4 T cells per cubic millimeter = 1.34, 95% CI = 1.08 to 1.66, P = .006) and non-statistically significantly increased risk of in situ vagina or vulva cancer (RR = 1.52, 95% CI = 0.99 to 2.35, P = .055) and of invasive cervical cancer (RR = 1.32, 95% CI = 0.96 to 1.80, P = .077). Among men, incidence (per 100 000 person-years) of in situ and invasive anal cancer was statistically significantly higher during 1996-2004 than during 1990-1995 (61% increase for in situ cancers, 18.3 cases vs 29.5 cases, respectively; RR = 1.71, 95% CI = 1.24 to 2.35, P < .001; and 104% increase for invasive cancers, 20.7 cases vs 42.3 cases, respectively; RR = 2.03, 95% CI = 1.54 to 2.68, P < .001). Incidence of other cancers was stable over time. Conclusions Risk of HPV-associated cancers was elevated among persons with AIDS and increased with increasing immunosuppression. The increasing incidence for anal cancer during 1996-2004 indicates that prolonged survival may be associated with increased risk of certain HPV-associated cancers.
引用
收藏
页码:1120 / 1130
页数:11
相关论文
共 41 条
  • [1] Highly active antiretroviral therapy and cervical squamous intraepithelial lesions in human immunodeficiency virus-positive women
    Ahdieh-Grant, L
    Li, R
    Levine, AM
    Massad, LS
    Strickler, HD
    Minkoff, H
    Moxley, M
    Palefsky, J
    Sacks, H
    Burk, RD
    Gange, SJ
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2004, 96 (14): : 1070 - 1076
  • [2] [Anonymous], 1992, MMWR Recomm. Rep, V41
  • [3] Appleby P, 2000, JNCI-J NATL CANCER I, V92, P1823, DOI 10.1093/jnci/92.22.1823
  • [4] AIDS-Related cancer and severity of immunosuppression in persons with AIDS
    Biggar, Robert J.
    Chaturvedi, Anil K.
    Goedert, James J.
    Engels, Eric A.
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2007, 99 (12) : 962 - 972
  • [5] The impact of highly active antiretroviral therapy and immunodeficiency on human papillomavirus infection of the oral cavity of human immunodeficiency virus-seropositive adults
    Cameron, JE
    Mercante, D
    O'Brien, M
    Gaffga, AM
    Leigh, JE
    Fidel, PL
    Hagensee, ME
    [J]. SEXUALLY TRANSMITTED DISEASES, 2005, 32 (11) : 703 - 709
  • [6] Cameron Jennifer E, 2007, Cancer Treat Res, V133, P185
  • [7] Chatterjee J, 2008, CHIM OGGI, V26, P4
  • [8] Human papillomavirus genotypes among women with HIV: implications for research and prevention
    Chaturvedi, Anil K.
    Goedert, James J.
    [J]. AIDS, 2006, 20 (18) : 2381 - 2383
  • [9] Cancer risk in the swiss HIV cohort study: Associations with immunodeficiency, smoking, and highly active antiretroviral therapy
    Clifford, GM
    Polesel, J
    Rickenbach, M
    Dal Maso, L
    Keiser, O
    Kofler, A
    Rapiti, E
    Levi, F
    Jundt, G
    Fisch, T
    Bordoni, A
    De Weck, D
    Franceschi, S
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2005, 97 (06): : 425 - 432
  • [10] Six-month natural history of oral versus cervical human papillomavirus infection
    D'Souza, Gypsyamber
    Fakhry, Carole
    Sugar, Elizabeth A.
    Seaberg, Eric C.
    Weber, Kathleen
    Minkoff, Howard L.
    Anastos, Kathryn
    Palefsky, Joel M.
    Gillison, Maura L.
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2007, 121 (01) : 143 - 150